0001127602-21-014341.txt : 20210423 0001127602-21-014341.hdr.sgml : 20210423 20210423162013 ACCESSION NUMBER: 0001127602-21-014341 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210422 FILED AS OF DATE: 20210423 DATE AS OF CHANGE: 20210423 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HENDERSON LORI M. CENTRAL INDEX KEY: 0001221127 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38753 FILM NUMBER: 21849948 MAIL ADDRESS: STREET 1: MOLDFLOW CORP STREET 2: 430 BOSTON POST ROAD CITY: WAYLAND STATE: MA ZIP: 01778 FORMER NAME: FORMER CONFORMED NAME: HENDERSON LORI M DATE OF NAME CHANGE: 20030228 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Moderna, Inc. CENTRAL INDEX KEY: 0001682852 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 813467528 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 TECHNOLOGY SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6177146500 MAIL ADDRESS: STREET 1: 200 TECHNOLOGY SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: Moderna Therapeutics, Inc. DATE OF NAME CHANGE: 20160822 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2021-04-22 0001682852 Moderna, Inc. MRNA 0001221127 HENDERSON LORI M. C/O MODERNA, INC. 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 1 General Counsel and Secretary Common Stock 2021-04-22 4 M 0 6600 20.93 A 7501 D Common Stock 2021-04-22 4 S 0 6600 168.26 D 901 D Stock Option (Right to Buy) 20.93 2021-04-22 4 M 0 6600 0 D 2029-03-08 Common Stock 6600 119876 D The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 23, 2020. 25% of this option vested and became exercisable on March 8, 2020 with the remainder vesting in twelve (12) equal quarterly installments thereafter. /s/ Brian Sandstrom, as Attorney-in-Fact 2021-04-23